17
Wednesday
October 2018
2:13 AM IST
News Headlines
Home   | Main News   | Kerala  | National   | International  | Business   | Sports   | Entertainment   | Columns   | Offbeat   | Health   | About Deepika 
Business News
Sun Pharma expects normalisation of India biz in FY'19
 
New Delhi, Oct 2 (PTI) Sun Pharma expects its India business to stabilise in the current fiscal leading to "reasonable volume growth" after witnessing disruptions in 2017-18 due to GST implementation, a top company official said.

In a message to shareholders in the company's Annual Report for 2017-18, Sun Pharma Managing Director Dilip Shanghvi however said the government's enforced price cuts and policy changes are potential risk factors for the business.

"We expect normalisation of the India business in 2018-19 post the disruption in 2017-18 due to GST implementation. Favourable demographics will ensure reasonable volume growth in India," Shanghvi said.

However, government-mandated price reductions/policy changes continue to be potential risks for this business, he added.

The company's India business revenues stood at Rs 8,029 crore in 2017-18, a growth of 4 per cent over 2016-17.

Shanghvi said the short-term outlook for the US generics market continues to be challenging given the pricing pressures.

"We are also expecting reasonable growth in our emerging markets business, however, as always, currency fluctuations continue to be a risk," he added.

Elaborating further, he said the company is in the process of gradually ramping up its global specialty business.

"We plan to increase its contribution to our consolidated revenues in the long term. This will entail significant front-ended investments, with commensurate revenue streams accruing only over a period of time," Shanghvi said.

Some of the company's specialty products are likely to be commercialised in the US in 2018-19 and hence it expects to incur significant pre-launch and branding costs along with increasing sales force costs, he added.

"Given these factors, we expect a low double-digit topline growth in our consolidated revenues for 2018-19 over 2017-18," Shanghvi said.

The Mumbai-based drug firm posted consolidated revenues of Rs 26,489.46 crore for 2017-18.

Shanghvi said the company's consolidated R&D investments for 2018-19 will be about 8-9 per cent of its revenues.


Infosys Q2 net profit grows 10.3% to Rs 4,110 crore
Trillions in US net worth vulnerable to recession: IMF
Will cause third World War if I join politics: Indra Nooyi
RBI springs surprise, keeps interest rates unchanged
IndiGo announces flights to Male, Phuket
Salaries in India may rise 10% in 2019, highest in Apac:Study
Govt to finalise Air India revival package in 10-15 days, says Choubey
Apple chief says firm guards data privacy in China
Govt plans Bharat-22 ETF listing on an overseas exchange
Innovations for festive sales help build capabilities for future, says Flipkart
Cabinet Gives Nod to New Telecom Policy to Create 40 Lakh Jobs
Cabinet okays Rs 4,500 crore package to sugar industry
Instagram departures hit Facebook shares
Sensex ends in red after 1,000-pt flash crash
OYO to hire over 2,000 tech experts, engineers by 2020
Sensex recovers over 100 points on value-buying, global cues
Deepak Kapoor Appointed the new Chairperson of Save the Children
RCom to exit telecom fully to focus on realty: Ambani
Petrol, diesel rates scale new highs
Adani Capital to raise Rs 1,000 cr in growth capital in FY19
KERALA NEWS
Sabarimala row: Protests against SC verdict continue
 Thiruvananthapuram: Members of the Opposition Congress and BJP in Kerala Friday staged demonstration  
Balabhaskar's wife Lakshmi shifted to ICU
Idukki dam's one shutter opened
Eight pacts signed after Modi-Putin summit
INTERNATIONAL NEWS
Flash floods kill at least 13 people in southwest France
 (Paris, oct 15, 2018):Flash floods tore through towns in southwest France, turning waterways
Prince Harry and wife Meghan expecting first baby next year
Death Toll in Afghanistan Election Rally Blast Climbs to 22
Kabul voters wrestle with newspaper-sized ballot paper
NATIONAL NEWS
Polling underway for last phase of municipal polls in J-K
 Srinagar: Polling was underway for the fourth and last phase of municipal elections in Jammu and Kas
Minister MJ Akbar Sues Journalist For Defamation Over #MeToo Allegations
Goa Congress Calls Cabinet Meeting in AIIMS 'Desperate Drama', Demands Parrikar's Resignation
‘Flogging a dead horse’: BJP’s comeback on Rahul’s attack on Rafale
Untitled Page
Rashtra Deepika LTD
Copyright @ 2018 , Rashtra Deepika Ltd.